Microvast Holdings announces departure of chief financial officer
Investing.com - Dentsply (NASDAQ: XRAY) reported fourth quarter EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $905M versus the consensus estimate of $922.82M.
Guidance
Dentsply sees FY 2025 EPS of $1.80-$2.00 versus the analyst consensus of $1.91.
Dentsply sees FY 2025 revenue of $3.50B-$3.60B versus the analyst consensus of $3.74B.
Dentsply’s stock price closed at $18.81. It is down -4.27% in the last 3 months and down -43.51% in the last 12 months.
Dentsply saw 0 positive EPS revisions and 14 negative EPS revisions in the last 90 days. See Dentsply’s stock price’s past reactions to earnings here.
According to InvestingPro, Dentsply’s Financial Health score is "fair performance".
Check out Dentsply’s recent earnings performance, and Dentsply’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar